Methods

(130) A comparison of the descriptive epidemiology derived from the GOLD and Aurum datasets in the Clinical Practice Research Datalink

(131) A Flexible Open-Source Analytic Pipeline for Self-Controlled Analysis of Real World Data

(132) A Framework for Rapid Analysis of Real-World Data in Safety Signal Assessment

(133) A novel estimation method for adjusting virtual inconsistency in a star-shaped network meta-analysis: an illustration of a case study

(134) A review of recommendations in guidelines on missing data in prediction modelling

(135) A semi-quantitative method to assess the likelihood of causality in observational studies

(136) A systematic review of algorithms used to identify neurodevelopmental disorders in electronic healthcare databases

(137) A Systematic Review to Summarize and Critically Appraise of Existing Phenotype Libraries Using Electronic Health Records- a FLOW study under the VAC4EU organisation

(138) An Application of Bayesian Modelling for Information Sharing in Safety Signal Detection

(139) An Evaluation of Patient Activity Definitions and Informative Censoring in Analyses of Real-World Overall Survival in Electronic Health Records (EHR) in the United States

(140) Application of capture-recapture method to estimate prevalence with registry data

(141) Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System

(142) Assessing the potential value of commercial mortality data combined with publicly available death data for pharmacoepidemiology research

(143) Assessment of the Application of a 90-Day-Gap Rule for Mitigating Frontline Treatment Sequence Misclassification in Electronic Health Records in the United States

(144) Comparison of multilevel propensity score estimation methods for tooth-clustered data in the evaluation of treatment effect in the presence of competing risks

(145) Critical Review of Dimensionality Reduction Approaches in Epidemiological Research

(146) Development and Indirect Validation of Patient Identification Algorithms to Identify Patients with Refractory Lupus using US Insurance Claims

(147) Development and Validation of a Novel Tool to Predict Hemoglobin A1c among Patients with Type 2 Diabetes, Using Administrative Claims Data

(148) Development and Validation of Text Mining Approach for Detecting Recurrence for Early Breast Cancer Patients: A Multi-institutional Study in Taiwan

(149) Development of Algorithms for the Implementation and Detection of Adverse Events in Routine Electronic Data Sources

(150) Effect of Race on Classification of Atherosclerotic Risk Using A National Cardiovascular Risk Prediction Tool

(152) Evaluating Methods to Define Place of Residence in Administrative Data and the Impact on Observed Associations

(153) Evaluating the Accuracy of Infant Weight and Length Measurements from Electronic Health Records for Use in Maternal Vaccination Safety Studies

(154) Fit-for-purpose evaluation of Real-World Data for vaccines and medicines safety studies: the INSIGHT tool

(155) Guidance for the Design of Observational Studies to Estimate the Effects of Long-term Drug Exposures

(156) High-dimensional propensity score implementation utilising electronic health records in Hong Kong

(157) Identification and Quantification of Barriers to Achieving Clinical Trial Diversity

(158) Identification of Valid Indicators for the Detection of Potentially Adverse Drug Event-Related Hospitalisations in Routine Electronic Data Sources: a RAND Survey

(159) Insomnia Symptom Prevalence in England: A Comparison of Self-Reported Data and Primary Care Records in the UK Biobank

(160) Intention to treat and on treatment exposure definition in observational safety studies: a simulation study using real world data

(161) Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide

(163) Methodological framework to conduct outcome validation in administrative or insurance claims and/or electronic healthcare record databases: a practical guide for pharmacoepidemiologists

(165) A hypothetical case study describing different intercurrent events in an observational prospective study: Differential interpretation of results

(165) Missing data analysis methods to correct outcome mismeasurement in pharmacoepidemiological studies using electronic medical information: Methodologies and recommendations for future validation studies

(166) A Novel, Hypothesis-free Approach to Detecting Safety Signals by Clustering Distributed Representations of Adverse Events Based on Claims Databases

(166) Model-based Meta-analysis: An Innovative and Robust Methodology for Clinical Decision Making

(167) A retrospective look at the efficiency of 100% source data verification and the possibilities presented by risk-based quality management in increasing monitoring efficiency while maintaining good data quality.

(167) Optimizing BMI Data Accuracy: Synergy Of Claims And EHR Databases

(168) A step-by-step guide for incorporating estimands in observational studies

(168) Outcome Validation to Assess Misclassification Bias in Studies Using Electronic Healthcare Claims

(169) Application of the Target Trial Emulation Framework to External Comparator Studies

(169) Quantification of information gained by linking claims data to an EHR cohort of US metastatic breast cancer (mBC) patients

(170) Minimizing Confounding in Comparative Observational Studies with Time-To-Event Outcomes: An Extensive Comparison of Covariate Balancing Methods Using Monte Carlo Simulation

(170) Quantifying Bias in Claims Safety Studies Arising from Medication Samples: A Simple Simulation

(171) Assessing the potential for sequential channeling bias for drugs with continuously expanded patient populations: an illustrative example using dupilumab

(171) Quantifying the impact of different look-back period criteria to identify new users when medication adherence is poor: A study of chronic medications for opioid use disorder

(172) Assessing the Use of the Estimand Framework in Recent Pharmacoepidemiologic Post-market Safety Studies

(172) Reporting of Harm from Randomized Clinical Trials in Medical Publications

(173) Characterization of treatment and disease burden of patients with bipolar disorder using Observational Medical Outcomes Partnership (OMOP) mapped datasets

(174) Comparing publicly available methods for assessing covariate balance using standardized differences after implementation of weighting strategies

(174) Standardization of Coding Definitions for Sickle Cell Disease Complications: A Systematic Literature Review

(175) The Use and Implementation of Instrumental Variables in Pharmacoepidemiology: A Scoping Review

(176) Translating population-level epidemiology to patient need

(177) Development and Clinical Validation of a Generative AI Assisted Medication-Indication Knowledge Base

(177) Validated case-identifying algorithms using Canadian administrative health data: a targeted literature review

(178) Enhancing Data Continuity: Tokenized Linkage Extends Patient Observations for Real World Evidence Generation - A Komodo Research Dataset Study

(178) Validation of Algorithms to Identify Breast Cancer and Bladder Cancer Among Patients With Type 2 Diabetes Mellitus in United States Medicare Administrative Claims

(179) Excluding or Censoring on Mediators and the Resulting Causal Estimands: An Example of Hormonal Contraceptives and Venous Thromboembolism Risk

(179) Validation of claims algorithm to identify HR+/HER2- metastatic breast cancer patients

(180) External Comparator Cohort studies – clarification of terminology

(180) Validation of claims-based algorithms for identifying neonatal urinary tract, genital, gastrointestinal, and musculoskeletal malformations in healthcare utilization databases

(181) External Comparators and Estimands

(181) Validation of obstetric diagnosis and procedure codes in the Danish National Patient Registry

(182) Factors associated with Remote Recruiting in Patient Centered Outcomes Research Studies

(182) Validation of Rhabdomyolysis in Claims Using Electronic Health Data in Taiwan

(183) Feasibility of Constructing an External Control Arm with Real-World Data to Augment Subgroups in Cardiorenal Trials: A Matched Cohort Study Focusing on Trial Subgroups of Sodium-Glucose Cotransport 2 Inhibitor Users at Baseline

(183) Validation study of the death information registered in BIFAP electronic health care records data source (Spain).

(184) Feasibility of the OMOP Common Data Model for German claims data

(185) Federated learning as a smart tool for data analysis in infectious disease research: a scoping review

(185) Validity of Out-of-Hospital and In-Hospital Cardiac Arrest Algorithms in the Danish National Patient Registry

(186) Who Should Be Prioritised For Primary Care Medication Review? Consensus Validation And Point Prevalence of Explicit Prescribing Indicators

(187) Identifying the average treatment effect in the treated: Illustration using the Northwest Germany Stroke Registry.

(187) Will Patients engage with Digiatl Technologies as part of Routine Healthcare?

(188) Improved Prediction of Overall Survival Using Machine Learning Survival Models Incorporating Time-Dependent Features

(189) Improving the Role of External Control Arms in Early-Phase Single Arm Trials

(191) Landscape Assessment of Clone-Censor-Weight Methodology Application in Real-World Data Studies: A Scoping Review

(192) Line of therapy algorithm for real-world data analysis in multiple myeloma

(193) Medication Data in Research: Improving Completeness Using Rule-based Algorithms on Textual Variables

(194) Ontology-based Semantic Similarity Measures in Drug Safety: A Literature Review

(195) Optimal matching ratios for the analysis of time-to-event outcomes in matched cohort studies in EHR research: A simulation study

(196) PRE2DUP-R, open source program for assessment of PREscriptions to Drug Use Periods

(197) Predicting CRC Screening Uptake using Machine Learning and Ensemble Models

(198) Predicting survival using geriatric assessment (GA) in older adults with advanced cancer using least absolute selection and shrinkage operator (LASSO)

(199) Proof-of-concept for a UK federated data network using the OMOP common data model: the UK regulatory studyathon

(201) Specifying the target trial reveals exceptions to commonly accepted rules of target trial emulation

(202) Systematic Definition Development of Variables of Interest for Studies Using Administrative Databases

(203) Testing machine learning prediction models to impute missing data in claims databases

(204) The Current Use of Single Arm Trials (SAT): A Targeted Literature Review

(205) There's something about Albumin: Applying the Roadmap for Causal Inference to Estimate the Effect of Albumin Levels on Pressure Injury Development in Hospital Settings

(207) Understanding the Utility of Historical Cohort Studies Via Retrospective Chart Review in Inflammatory Bowel Disease: A Review of Global Studies

(208) Using large language models with real world data to support regulatory decision-making for medicinal products: Are we on the road to regulatory convergence or chaos?

(209) What Exactly Does Clone-Censor-Weighting Estimate When Studying Treatment Initiation Windows, Anyway?